Close

Mylan (MYL), Actavis (ACT) Continue Lower Following CVS/Cardinal Health Agreement

December 10, 2013 12:10 PM EST
Mylan (Nasdaq: MYL), Actavis (NYSE: ACT) are lower Tuesday following CVS (NYSE: CVS) and Cardinal Health (NYSE: CAH) reaching a new generic sourcing entity agreement with Cardinal Health, which is said to be the largest in the U.S.

Mylan is down 3.4 percent, while Actavis is down 2.5 percent.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Insiders' Blog, Trader Talk